QQ客服 官方微博 反馈留言

浏览/检索结果: 共11条，第1-10条 帮助 限定条件 内容类型：会议论文     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 A randomized phase II trial of pyrotinib plus capecitabine versus lapatinib plus capecitabine in patients with HER2-positive metastatic breast cancer previously treated with taxanes, anthracyclines and/or trastuzumab 会议论文 作者:  Xu, Binghe;  Ma, Fei;  Ouyang, Quchang;  Li, Wei;  Jiang, Zefei 收藏  |  浏览/下载：10/0  |  提交时间：2019/12/05 A randomized phase II trial of pyrotinib plus capecitabine versus lapatinib plus capecitabine in patients with HER2-positive metastatic breast cancer previously treated with taxanes, anthracyclines and/or trastuzumab 会议论文 CANCER RESEARCH, 2018-02-01 作者:  Xu, Binghe;  Ma, Fei;  Ouyang, Quchang;  Li, Wei;  Jiang, Zefei 收藏  |  浏览/下载：15/0  |  提交时间：2020/01/03 Randomized phase III trial of utidelone, a genetically engineered epothilone analog, in combination with capecitabine versus capecitabine alone for metastatic breast cancer patients with previous taxane and anthracycline treatment. 会议论文 JOURNAL OF CLINICAL ONCOLOGY, 2016-05-20 作者:  Xu, Binghe;  Sun, Tao;  Zhang, Qingyuan;  Yuan, Zhongyu;  Zhang, Pin 收藏  |  浏览/下载：4/0  |  提交时间：2020/01/04 A phase III study of fulvestrant 500 mg versus 250 mg in postmenopausal Chinese women with advanced breast cancer and disease progression following failure on prior antiestrogen or aromatase inhibitor therapy: Supporting superior clinical benefit for the 会议论文 作者:  Jiang, Zefei;  Zhang, Qingyuan;  Shao, Zhimin;  Shen, Kunwei;  Li, Li 收藏  |  浏览/下载：59/0  |  提交时间：2019/12/13 Phase 3, randomized, double-blind, placebo-controlled multicenter trial of daily everolimus plus weekly trastuzumab and paclitaxel as first-line therapy in women with HER2+advanced breast cancer: BOLERO-1 会议论文 作者:  Hurvitz, Sara A.;  Andre, Fabrice;  Jiang, Zefei;  Shao, Zhimin;  Neciosup, Silvia P. 收藏  |  浏览/下载：8/0  |  提交时间：2019/12/19 Gemcitabine with cisplatin or paclitaxel in metastatic triple-negative breast cancer 会议论文 作者:  Hu, Xichun;  Xu, Binghe;  Cai, Li;  Wang, Zhonghua;  Wang, Biyun 收藏  |  浏览/下载：4/0  |  提交时间：2019/12/19 A phase III study of fulvestrant 500 mg versus 250 mg in postmenopausal Chinese women with advanced breast cancer and disease progression following failure on prior antiestrogen or aromatase inhibitor therapy: Supporting superior clinical benefit 会议论文 CANCER RESEARCH, 2015-05-01 作者:  Jiang, Zefei;  Zhang, Qingyuan;  Shao, Zhimin;  Shen, Kunwei;  Li, Li 收藏  |  浏览/下载：8/0  |  提交时间：2020/01/04 Gemcitabine with cisplatin or paclitaxel in metastatic triple-negative breast cancer 会议论文 CANCER RESEARCH, 2015-05-01 作者:  Hu, Xichun;  Xu, Binghe;  Cai, Li;  Wang, Zhonghua;  Wang, Biyun 收藏  |  浏览/下载：3/0  |  提交时间：2020/01/04 Is vinorelbine pharmacokinetics modified in Asian patients when compared to caucasian patients? 会议论文 作者:  Ferre, Pierre;  Shao, Zhimin;  Jiang, Zefei;  Zhong, Dafang;  Chen Xiaoyan 收藏  |  浏览/下载：17/0  |  提交时间：2019/01/08 Is vinorelbine pharmacokinetics modified in Asian patients when compared to caucasian patients? 会议论文 作者:  Ferre, Pierre;  Shao, Zhimin;  Jiang, Zefei;  Zhong, Dafang;  Chen Xiaoyan 收藏  |  浏览/下载：5/0  |  提交时间：2019/12/19